Rituximab in Patients With Acute Rheumatic Fever
Clinical trial NCT05682196 · SUSPENDED
Trial details
- NCT number
- NCT05682196
- Sponsor
- African Academy of Methodology and Statistics
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-05
- Primary completion
- 2024-09-30
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.